Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland

• Anna Sarah Messmer, MD,
• Yok-Ai Que, MD, PhD,
• Christoph Schankin, MD, PhD,
• Yara Banz, MD, PhD,
• Ulrike Bacher, MD,
• Urban Novak, MD,
• Thomas Pabst, MD

Affiliations

Anna Sarah Messmer, MD

1 Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Yok-Ai Que, MD, PhD

1 Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Christoph Schankin, MD, PhD

2 Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Yara Banz, MD, PhD

3 Institute of Pathology, University of Bern, Bern, Switzerland

Ulrike Bacher, MD

4 Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Urban Novak, MD

5 Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Thomas Pabst, MD

5 Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland